0.04Open0.05Pre Close8 Volume59 Open Interest2.50Strike Price37.00Turnover1070.39%IV1043.50%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.3711Delta0.8952Gamma4.46Leverage Ratio-0.0070Theta0.0000Rho1.66Eff Leverage0.0001Vega
Viracta Therapeutics Stock Discussion
1 min ago
Viracta Therapeutics Announces Closure of Naval-1 Clinical Trial and Exploration of Strategic Alternatives
Viracta Therapeutics Inc - Closure of Trial Not Due to New Safety Finding
Viracta Therapeutics Inc - Potential Alternatives Include Merger, Licensing Agreement, Sale
No comment yet